Related references
Note: Only part of the references are listed.Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome
Nakwon Kwak et al.
CHEST (2021)
Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend
David E. Griffith et al.
CHEST (2021)
First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
Kiyoharu Fukushima et al.
SCIENTIFIC REPORTS (2021)
Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease
Seong Mi Moon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex pulmonary disease
Hadeel Khadawardi et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Treatment for Mycobacterium avium complex lung disease
Sheng-Wei Pan et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Outcome of shorter treatment duration in non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease
Yea Eun Park et al.
JOURNAL OF THORACIC DISEASE (2020)
Long-Term Treatment Outcome of Progressive Mycobacterium avium Complex Pulmonary Disease
Kiyoharu Fukushima et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Charles L. Daley et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonaryMycobacterium aviumcomplex disease: A propensity score analysis
Hisayuki Shuto et al.
PLOS ONE (2020)
Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy
Yasuhiro Ito et al.
RESPIRATORY MEDICINE (2020)
Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in Mycobacterium avium Complex Lung Disease
Yong Shik Kwon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Sitafloxacin-Containing Regimen for the Treatment of Refractory Mycobacterium avium Complex Lung Disease
Takanori Asakura et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
Dae Hun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
Hyung-Jun Kim et al.
BMC PULMONARY MEDICINE (2019)
Treatment of Mycobacterium avium Complex Pulmonary Disease
Yong-Soo Kwon et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2019)
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
Jakko van Ingen et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad et al.
LANCET (2018)
Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
Won-Jung Koh et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Linezolid as treatment for pulmonary Mycobacterium avium disease
Devyani Deshpande et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China
Yu Pang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
Julie Jarand et al.
CHEST (2016)
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases
Kozo Morimoto et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Intermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
Byeong-Ho Jeong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Tuberculosis, Pulmonary Cavitation, and Matrix Metalloproteinases
Catherine W. M. Ong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy
Kyung-Wook Jo et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen
Won-Jung Koh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
Susan E. Dorman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Share Paper
